Abstract: At the same smoking level, women have a higher risk of lung cancer. The aim of the study was to evaluate epidemiological, clinical and histological profile of women's lung cancer. A retrospective study including women patients with a confirmed lung cancer followed at
Introduction


At the same smoking level, women have a higher risk of lung cancer than men. Besides smoking, other factors appear to be related to lung cancer in women because 30% of women with lung cancer are non-smoking [1] . During the last 100 years, lung cancer was considered a predominantly male disease. Currently, although lung cancer remains common in men than women, the difference between the two genders tends to be shorter [2] . The aim of the study was to evaluate epidemiological, clinical and histological profile of women's lung cancer.
Materials and Methods
Retrospective study including patients with a confirmed lung cancer followed at the Pneumology Department of University Hospital Center Mohammed VI, of Marrakesh in Morocco between January 2010 and December 2014. Collecting data was performed using a questionnaire filled in by the investigator including the following items: general characteristics,
Results
Clinical Features
14 cases have been collected in the study. The average age of our patients was 54.2 years, ranging from 38 to 72 years. A low socioeconomic level was noted in 13 cases (92.8%). Data on occupation and occupational exposures are reported in Table 1 .
Active smoking was noted in 2 patients (14.4%). Passive smoking has been reported in 6 cases (42.8%). First symptoms revealing the disease are reported in Table 2 .
Data on the performance status of the patients are reported in Table 3 .
Radiological Aspects
On standard chest X-ray, radiological aspects are reported in Table 4 . 
Evaluation of Lymph Node Status "N"
10 cases were evaluated as N2, N3 were 4 cases.
Evaluation of Distance Extension "M"
All patients had a brain CT scan and abdominal ultrasonography. None of our patients had PET scan, it is unavailable. 9 patients had least one metastatic site which are reported in Table 5 .
Stage of the Disease
The distribution of patients depending on the stage of the disease is reported in Figure 1 .
Histology
Diagnosis Confirmation
Histological confirmation was obtained in 10 cases (71.4%) by bronchial biopsy, 2 cases with pleural biopsy (14.4%), 1 case by lymph node biopsy (7.1%) and a case transparietal biopsy (7.1%).
Histological Types
The histological types found are reported in Figure 2 . Clinical features are summarized in Table 6 .
Treatment
None of our patients received surgical treatment. The treatment proposed for these patients according to the stage of disease and performance status are reported in Table 7 .
Evolution
Mortality at one year was 92.8%. The causes of death were dominated by thromboembolic diseases.
Discussion
During the last 100 years, lung cancer was considered a predominantly male disease. Currently, although lung cancer remains common in men than women, the difference between the two genders tends to be shorter [2] . In the United States, lung cancer mortality has surpassed the breast cancer one since 1987 (even if the breast cancer still is of course the most common women's cancer). In Europe, the sex ratio varies greatly across countries reflect differences in smoking habits. The lowest sex ratio is in Denmark at 1.7, while it is the highest in Spain at 13.4. In France, lung cancer was the sixth leading cause of cancer death in women in 1985 and rose to 3rd place in 1995 [3] . In 2015, Malvezzi et al. says that the mortality of lung cancer among European women might exceed the breast cancer one [4] .
The average age of developing lung cancer in women is lower than men. In our series, the average age is 54.2 years. According Radzikowska et al., in a series of 2,875 women with lung cancer, young women develop more lung cancer than men, this difference is greater for adenocarcinoma type of cancer [5] .
In some studies, age at diagnosis is higher in women than in men [6] , while in others, it is the opposite [5] . These discrepancies may be related to the proportion of non-smokers in these series. Non-smokers have a higher age at diagnosis than smokers [7] . The proportion of lung cancer due to smoking is lower by half in women compared to men. In 2000, it is estimated that over the world 85% of lung cancers in men are related to tobacco against only 47% in women [8] . This suggests a feminine susceptibility to lung cancer [2, 9] . Currently, the involvement of hormonal factor in the genesis of lung cancer is no longer any doubt; the estradiol plays a role of promoter for the growth of both lung fibroblasts and lung cancer cells [9] . Hormonal replacement therapy is associated with an increased incidence and mortality of lung cancer in women [9] .
The incidence of lung cancer in women is growing exponentially this seems correlated with the increase
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in smoking among women [1, 10] . Besides smoking, other factors appear to be related to lung cancer in women, with 30% of women with lung cancer are non-smoking [11] . In the study of Foegle, about 1,738 cases of lung cancer diagnosed in Bas-Rhine, it was noted 1.4% of non-smoking male cancer against 28.9% in women [12] . In Morocco, lung cancer incidence among men is 24.8/100,000 while in women the incidence is 3.4/100,000, this is correlated with the prevalence of smoking in Morocco which is 31.5% of men and 3.3% of women [13] . In our series, 85.7% of patients were non-smokers; this could be explained by a lower prevalence of smoking among women in Morocco. Tobacco is the main risk factor in women found in most series [1, 10, 11] , in our series passive smoking was noted in 42.8%. According Boffetta, passive smoking is implicated in women in 14.2% of cancer cases [6] .
Smoking is related to an increase of incidence of all histological types with a dose-effect relationship [5] . Adenocarcinoma is the most common histological type in women regardless smoking status. The second frequency is lung small cell carcinoma. Although adenocarcinoma is increasing in men in France (with a delay of several years compared to North America), squamous lung cancer remains the most common histological type in men in Europe [14] . In our series adenocarcinoma was found in 64.3%. Besides smoking, other risk factors are implicated. In our series 64.2% of women are exposed at least to one carcinogenic domestic pollutant.
Most studies have shown a greater susceptibility of women to lung cancer [3] . The female gender seems to be a poor prognosis factor in lung cancer [3] . In our series, all patients had an advanced stage of disease at diagnosis (stage III or IV) with 64.2% stage IV cancer. Besides genetic susceptibility of women, in our context, other factors may delay the diagnosis explained in this population by a low socioeconomic level, health care access problems and the hesitancy of women to report smoking for cultural reasons.
In 2008, 5-year survival in France in women lung cancer patients was 17% for all stages in contrast to men which was 13% [15] . Survival is strongly correlated with the stages of the disease, the survival passes from 15% for stage III to 1% for stage IV [16] . In our series, survival is particularly low (7.4%) due to the diagnosis of the disease at late stages.
Conclusions
The study shows that the lung cancer in women, in our context, occurs more often in non-smoker patients, usually an adenocarcinoma type and discovered at late stages.
